NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab

Código QR

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab

Alfredomaria Lurati, Luca Bertani, Mariagrazia Marrazza, Katia Angela Re, Daniela Bompane, Magda ScarpelliniRheumatology Unit, Fornaroli Hospital, Magenta, ItalyPurpose: The relationship between antiCD20 therapy with rituximab and the lymphocytes phenotype in patients with rheumatoid arthritis was i...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Re KA, Marrazza M, Bertani L, Lurati A, Scarpellini M, Bompane D
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/c6faa4f926904747943482ce1ce7ba1c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

NK cell count as predictor of clinical response in patients with rheumatoid arthritis treated with rituximab [Corrigendum]
por: Lurati A, et al.
Publicado: (2013)

Improvement of HbA1c in Patients with Type 2 Diabetes Mellitus and Rheumatoid Arthritis Treated with bDMARDs
por: Lurati A, et al.
Publicado: (2021)

Safety of etanercept in elderly subjects with rheumatoid arthritis
por: Alfredomaria Lurati, et al.
Publicado: (2009)

Rituximab therapy in Greek patients with rheumatoid arthritis
por: Haralampos M Moutsopoulos, et al.
Publicado: (2008)

Update on the use of rituximab for intractable rheumatoid arthritis
por: R John Looney
Publicado: (2009)

Tuberculosis Arthritis in the Wrist While Using Rituximab for Rheumatoid Arthritis Treatment
por: Ulusoy H, et al.
Publicado: (2020)

B cell reductive therapy with rituximab in the treatment of rheumatoid arthritis
por: Joseph M Tuscano, et al.
Publicado: (2009)

The macrophages in rheumatic diseases
por: Laria A, et al.
Publicado: (2016)

Factors correlated with improvement of endothelial dysfunction during rituximab therapy in patients with rheumatoid arthritis
por: Benucci M, et al.
Publicado: (2013)

Goals for rheumatoid arthritis: treating to target or treating to prevent?
por: Yang M, et al.
Publicado: (2012)

Different T cells' distribution and activation degree of Th17 CD4+ cells in peripheral blood in patients with osteoarthritis, rheumatoid arthritis, and healthy donors: preliminary results of the MAGENTA CLICAO study
por: Lurati A, et al.
Publicado: (2015)

Tender and swollen joint counts are poorly associated with disability in chikungunya arthritis compared to rheumatoid arthritis
por: Hugh Watson, et al.
Publicado: (2021)

Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis
por: Hasan E, et al.
Publicado: (2012)

Baseline predictors of remission, pain and fatigue in rheumatoid arthritis: the TITRATE trial
por: Sook Yan Lee, et al.
Publicado: (2021)

Rheumatoid arthritis hand lesions assessed with outcome measures in rheumatoid arthritis clinical trials-rheumatoid arthritis magnetic resonance imaging score – proposing an extended rheumatoid arthritis magnetic resonance imaging score
por: M. del Carmen Larios-Forte, et al.
Publicado: (2021)

Bone-sparing effects of rituximab and body composition analysis in a cohort of postmenopausal women affected by rheumatoid arthritis – retrospective study
por: Suhel Gabriele Al Khayyat, et al.
Publicado: (2021)

Reappraisal of the clinical use of leflunomide in rheumatoid arthritis and psoriatic arthritis
por: Peter BB Jones, et al.
Publicado: (2010)

Osteosarcopenia in rheumatoid arthritis treated with glucocorticosteroids – essence, significance, consequences
por: Marcin Radkowski, et al.
Publicado: (2020)

Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNF&alpha; blocker failure
por: Kekow J, et al.
Publicado: (2012)

Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results
por: Santos-Moreno P, et al.
Publicado: (2020)

CLINICAL AND IMMUNOLOGICAL PARAMETERS IN EARLY RHEUMATOID ARTHRITIS
por: V. V. Sokolova, et al.
Publicado: (2014)

Predictors for clinical effectiveness of baricitinib in rheumatoid arthritis patients in routine clinical practice: data from a Japanese multicenter registry
por: Nobunori Takahashi, et al.
Publicado: (2020)

Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
por: Ríos C, et al.
Publicado: (2017)

Revealing the efficacy-toxicity relationship of Fuzi in treating rheumatoid arthritis by systems pharmacology
por: Wuwen Feng, et al.
Publicado: (2021)

BAFF predicts immunogenicity in older patients with rheumatoid arthritis treated with TNF inhibitors
por: Borja Hernández-Breijo, et al.
Publicado: (2021)

Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
por: Cutolo M, et al.
Publicado: (2013)

Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.
por: Ceara E Walsh, et al.
Publicado: (2011)

PREDICTION OF CLINICAL EFFICIENCY OF SIMVASTATIN TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
por: I. V. Shirinsky, et al.
Publicado: (2014)

Molecular and Cellular Heterogeneity in Rheumatoid Arthritis: Mechanisms and Clinical Implications
por: Jianan Zhao, et al.
Publicado: (2021)

STUDIES OF SEVERAL BLOOD CYTOKINES IN PATIENTS WITH RHEUMATOID ARTHRITIS: CLINICAL AND IMMUNOLOGAL INTERRRELATIONS
por: M. V. Pachkunova, et al.
Publicado: (2014)

Baricitinib for the treatment of rheumatoid arthritis
por: Ivan Urits, et al.
Publicado: (2020)

Management of Rheumatoid Arthritis: An Overview
por: Andrei-Flavius Radu, et al.
Publicado: (2021)

The prevalence of rheumatoid arthritis in Spain
por: Lucía Silva-Fernández, et al.
Publicado: (2020)

Rheumatoid arthritis: Disease or syndrome?
por: Jessica A Stanich, et al.
Publicado: (2009)

Infliximab in the treatment of rheumatoid arthritis
por: A Perdriger
Publicado: (2009)

Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
por: Bogdan Batko, et al.
Publicado: (2018)

Mixed Cryoglobulinaemia Vasculitis Treated with Obinutuzumab in a Patient Allergic to Rituximab
por: Margarida Gaudencio, et al.
Publicado: (2021)

Color duplex ultrasonography findings of temporal arteries in a case of giant cell arteritis: role in diagnosis and follow-up
por: Laria A, et al.
Publicado: (2017)

Humoral Response to Microbial Biomarkers in Rheumatoid Arthritis Patients
por: Seyedesomaye Jasemi, et al.
Publicado: (2021)

Cold-induced urticaria associated with type I cryoglobulinemia, successfully treated with rituximab
por: Leonie C. Stroet, MD, et al.
Publicado: (2022)